EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

DNAzymes and Oligodeoxyribonucleotides Immobilized on Aminopropylsilanol and Polylysine‐Anatase Nanoparticles as Active Agents Against Influenza A/ H5N1 Virus

Marina Repkova iD, Asya Levina iD, Ekaterina Filippova, Elena Makarevich, Maria Protsenko, Larisa Shishkina, Artemiy Sergeev, Valentina Zarytova iD

Chemical Biology & Drug Design · 2026

DOI: 10.1111/cbdd.70419 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2026. Written by Marina Repkova and 7 co-authors. Institution: Institute of Chemical Biology and Fundamental Medicine, SB RAS, Novosibirsk, Russia. Major MEDLINE topics: Influenza A Virus, H5N1 Subtype, Oligodeoxyribonucleotides, Polylysine, Antiviral Agents. 25 references. The full text is freely available (open access, CC BY 4.0). Funded by: Russian state-funded project for ICBFM SB RAS, State Research Center of Virology and Biotechnology "Vector," Russia.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The nanocomposites based on aminopropylsilanol (Si~NH 2 ) and polylysine‐anatase (Ans/PL) nanoparticles bearing DNAzymes (Dz) and oligodeoxyribonucleotides (ON) can effectively inhibit the replication of the influenza A/H5N1 virus in cell culture. Nanocomposites based on both types of nanoparticles exhibit high activity. The Dz‐containing nanocomposites exhibited higher antiviral activity than those containing ON, reducing influenza A/H5N1 virus production by 3.5 log versus 2.4–3.0 log, respectively. Notably, the effect of Dz incorporated into the nanoparticles was an order of magnitude higher than that of unbound Dz transfected with lipofectamine. Nanocomposites carrying control DNA fragments that are not specific to the influenza A virus genome have practically no antiviral activity, indicating the specificity of the proposed nanocomposites. It was demonstrated that the antiviral efficacy of the nanocomposites is primarily determined by the activity of DNA delivered into cells, which can be varied by altering either the nanocomposite concentration or its capacity for DNA fragments. All of the proposed nanocomposites can be considered as potential antiviral drugs.

Subjects

MeSH terms (MEDLINE)

Influenza A Virus, H5N1 SubtypeOligodeoxyribonucleotidesPolylysineAntiviral AgentsSilanesNanoparticlesAnimalsNanocompositesDogsMadin Darby Canine Kidney CellsVirus ReplicationHumans

Author keywords

DNAzymesanatase and aminopropylsilanol nanoparticlesinhibition of influenza A/H5N1 virusnanocompositesoligodeoxyribonucleotides

Substances

OligodeoxyribonucleotidesPolylysineAntiviral AgentsSilanes

Authors and institutions

  • Institute of Chemical Biology and Fundamental Medicine, SB RAS, Novosibirsk, Russia.
  • FBRI State Research Center of Virology and Biotechnology "Vector" of Rospotrebnadzor, Koltsovo, Novosibirsk Region, Russia.

ORCID profiles: Marina Repkova, Asya Levina, Valentina Zarytova

Funding

  • Russian state-funded project for ICBFM SB RAS
  • State Research Center of Virology and Biotechnology "Vector," Russia

Cite

APA

Repkova, M., Levina, A., Filippova, E., Makarevich, E., Protsenko, M., Shishkina, L., Sergeev, A., & Zarytova, V. (2026). DNAzymes and Oligodeoxyribonucleotides Immobilized on Aminopropylsilanol and Polylysine‐Anatase Nanoparticles as Active Agents Against Influenza A/ H5N1 Virus. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70419

Vancouver

Repkova M, Levina A, Filippova E, Makarevich E, Protsenko M, Shishkina L, et al. DNAzymes and Oligodeoxyribonucleotides Immobilized on Aminopropylsilanol and Polylysine‐Anatase Nanoparticles as Active Agents Against Influenza A/ H5N1 Virus. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70419

BibTeX
@article{Repkova2026,
  author = {Repkova, Marina and Levina, Asya and Filippova, Ekaterina and Makarevich, Elena and Protsenko, Maria and Shishkina, Larisa and Sergeev, Artemiy and Zarytova, Valentina},
  title = {DNAzymes and Oligodeoxyribonucleotides Immobilized on Aminopropylsilanol and Polylysine‐Anatase Nanoparticles as Active Agents Against Influenza A/ H5N1 Virus},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  doi = {10.1111/cbdd.70419}
}
Start for free →